Results 181 to 190 of about 329,096 (211)
Some of the next articles are maybe not open access.

Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

Seminars in Radiation Oncology, 2017
The rising incidence of early-stage lung cancer, particularly in medically inoperable patients, is anticipated because of the implementation of early detection strategies and population aging in the United States and worldwide. This mandates the development of noninvasive curative treatment approaches for this disease.
Jennifer L, Shah, Billy W, Loo
openaire   +2 more sources

Historical Development of Stereotactic Ablative Radiotherapy

2012
Stereotactic radiosurgery (SRS) has been an effective modality for the treatment of benign and malignant cranial disease for over 50 years. Just as SRS revolutionized the practice of neurosurgery, stereotactic ablative radiotherapy (SAbR) in extracranial sites is now challenging conventional wisdom with regard to the practice of radiation oncology ...
Timothy D. Solberg   +2 more
openaire   +1 more source

Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer

Surgical Oncology Clinics of North America, 2016
The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co ...
Ghulam, Abbas   +2 more
openaire   +2 more sources

A national dosimetry audit for stereotactic ablative radiotherapy in lung

Radiotherapy and Oncology, 2017
A UK national dosimetry audit was carried out to assess the accuracy of Stereotactic Ablative Body Radiotherapy (SABR) lung treatment delivery.This mail-based audit used an anthropomorphic thorax phantom containing nine alanine pellets positioned in the lung region for dosimetry, as well as EBT3 film in the axial plane for isodose comparison.
Distefano, Gail   +6 more
openaire   +3 more sources

Stereotactic Ablative Radiotherapy Uncertainties: Delineation, Setup and Motion

Seminars in Radiation Oncology, 2018
Stereotactic ablative radiotherapy (SAbR), also known as stereotactic body radiation therapy, is biologically distinct from conventionally fractionated radiotherapy in that it is ablative, causing functional incapacitation of targeted tissue including margins added to avoid errors.
Ming, Yang, Robert, Timmerman
openaire   +2 more sources

Stereotactic Ablative Radiotherapy for ‘Oligometastases’: a Treatment in Search of Evidence

Clinical Oncology, 2016
For over 30 years, metastasectomy has been seen as standard practice for patients with soft tissue sarcoma or osteosarcoma and lung metastases [1]. For 10 years, liver metastases have been resected from patients with colorectal cancer and metastasectomy has become one of the more frequently performed liver operations in the UK [2e4].
F, Macbeth, T, Treasure
openaire   +2 more sources

Functional Outcomes of Stereotactic Ablative Radiotherapy: There Is Room for Improvement

European Urology Oncology
N.A.
Bertolo, Riccardo   +2 more
openaire   +2 more sources

Radiobiology of Stereotactic Body Radiation Therapy/Stereotactic Ablative Radiotherapy

2012
Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) is rapidly being adopted as a treatment modality, particularly for liver and lung tumors, and because of the dramatic improvements in tumor control, the use of SBRT is being directed toward other anatomical sites.
Michael D. Story   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy